Antibiotic Resistance and β-Lactamases Detection of Serratia

周田美,董晓勤,俞云松,王杰,余道军,周志慧
DOI: https://doi.org/10.3321/j.issn:1005-4529.2005.01.037
2005-01-01
Abstract:OBJECTIVE To investigate the Serratia′s resistance in Hangzhou and the detection rates of AmpC ~β-lactamase (AmpC) and extended-spectrum β-lactamases (ESBLs), which would help treat infectious diseases in clinic. METHODS The drug sensitivity test of 148 strains of Serratia was done by Kirby-Bauer test. The ~AmpC enzymes and ESBLs were detected by phenotype screening and three-dimensional tests. RESULTS Among 148 strains of Serratia, the resistant rates to ampicillin, cefuroxime, amoxicillin/clavulanate were above 80%, and to imipenem, cefepime, trimethoprim/sulfamethoxazole, ciprofloxacin and other antibiotics were below 10%, while to cefoxitin was 31.1%. There were 18 strains (12.2%) producing AmpC enzymes, and 4 strains ~(2.7%) producing AmpC enzymes and ESBLs simnltaneously. The enzyme-produced strains were resistant to many antibiotics. CONCLUSIONS The producing of AmpC enzymes and ESBLs leads to the Serratia′s resistance to many antibiotics in Hangzhou, and the strains producing AmpC enzymes are more than that producing ESBLs. The antibiotics should be used reasonably according to the results of drug sensitivity test in clinic.
What problem does this paper attempt to address?